Axcella health inc. (AXLA)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities:
Net loss

-62,473

-59,037

-53,086

-44,566

-39,542

-36,069

0

0

0

Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

600

700

700

900

900

1,100

0

0

0

Stock-based compensation expense

6,286

5,824

5,203

4,344

3,547

2,778

0

0

0

Change in fair value of preferred stock warrant liability

0

51

111

106

102

14

0

0

0

Non-cash interest expense

537

557

623

614

607

529

0

0

0

Changes in current assets and liabilities:
Prepaid expenses and other current assets

-307

652

2,601

3,323

1,516

580

0

0

0

Accounts payable

-778

366

2,432

463

1,162

595

0

0

0

Accrued expenses and other current liabilities

0

-

0

0

0

-

0

0

0

Net cash used in operating activities

-55,296

-50,962

-45,151

-40,493

-34,784

-30,712

0

0

0

Cash flows from investing activities:
Purchases of property and equipment

89

136

275

220

418

659

0

0

0

Net cash used in investing activities

-70

-117

-256

-220

-345

-586

0

0

0

Cash flows from financing activities:
Payment of deferred offering costs

0

-

-

-

0

-

-

-

0

Proceeds from issuance of long term debt

-

-

-

-

-

6,000

0

0

0

Payment of debt issuance costs

-

-

-

-

-

945

0

0

0

Proceeds from exercise of common stock options

328

340

259

268

57

45

0

0

0

Net cash used in financing activities

64,119

63,666

127,317

127,729

63,338

63,947

0

0

0

Net decrease in cash and cash equivalents

8,753

12,587

81,910

87,016

28,209

32,649

0

0

0

Supplemental cash flow information:
Cash paid for interest

2,792

2,838

2,750

2,603

2,435

2,255

0

0

0

Deferred offering costs included in accounts payable and accrued expenses

0

-

-

-

0

-

-

-

0

Purchases of property and equipment included in accounts payable and accrued expenses

0

-

-

-

0

-

-

-

-